Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism-Reference-Cited by-同舟云学术

Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism

Published:2018-05-07 Issue:7 Volume:46 Page:1001-1013
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Glaenzel Ulrike,Jin Yi,Nufer Robert,Li Wenkui,Schroer Kirsten,Adam-Stitah Sylvie,Peter van Marle Sjoerd,Legangneux Eric,Borell Hubert,James Alexander D.,Meissner Axel,Camenisch Gian,Gardin Anne

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference26 articles.

1. FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis

2. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions;Brana;Neuropathol Appl Neurobiol,2014

3. Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology

4. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

5. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structuring expert review using AOPs: Enabling robust weight-of-evidence assessments for carcinogenicity under ICH S1B(R1);Computational Toxicology;2024-09

2. Optimization of therapy in secondary progressive multiple sclerosis;Neurology, Neuropsychiatry, Psychosomatics;2024-08-07

3. Biotransformation research advances – 2023 year in review;Drug Metabolism Reviews;2024-07-11

4. Кыргыз Республикасында демиелинизациялык ооруларды дарылоонун мүмкүнчүлүктөрү;Scientific and practical journal Healthcare of Kyrgyzstan;2024-05-10

5. 1-Phosphate receptor agonists: A promising therapeutic avenue for ischemia-reperfusion injury management;International Immunopharmacology;2024-04